Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2018 | Promising POUT: perioperative chemotherapy for upper tract urothelial cancer

Robert Jones • 8 Feb 2018
GU Cancers 2018
Bladder Cancer Genitourinary Cancer
POUT

The UK was well represented at the Genitourinary Cancers Symposium 2018, held in San Francisco, CA. In this video, Robert Jones, PhD, of the University of Glasgow & Beatson West of Scotland Cancer Centre, Glasgow, UK, discusses the Phase III Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer trial (POUT; NCT01993979). Prof. Jones emphasizes the importance of this trial, in both the type of cancer studied and the practice-changing potential of the results.

More from Robert Jones

2:04
Areas of unmet need in metastatic urothelial carcinoma
Robert Jones • 4 Jun 2022
1:10
ASCO 2022: genitourinary cancer highlights
Robert Jones • 4 Jun 2022
0:58
Replacing the current standard of care for urothelial carcinoma
Robert Jones • 4 Jun 2022
2:19
Final results from ATLANTIS cabozantinib arm for urothelial carcinoma
Robert Jones • 4 Jun 2022

Related Videos

0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
1:08
PSMA imaging pre- and post-177Lu-PSMA-617 treatment in mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
1:08
Guideline concordance in managing mHSPC
Hannah McManus • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals